JMP keeps Align Technology at market outperform

Align Technology, Inc. was maintained at market outperform and an $11 price target by JMP Securities analyst Anthony Ostrea. The company filed another suit against OrthoClear; alleging false advertising, trade libel, defamation, and unfair competition. Align could be in line for monetary damages. Shares of the Reston, Va.-based manufacturer of Invisalign were down 7 cents, or 0.92%, at $7.55 on volume of 296,343 shares versus the three-month running average of 522,745 shares. (Nasdaq: ALGN)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.